We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Indirect Approach Uses Yeast to Identify Function of Malaria Genes

By LabMedica International staff writers
Posted on 08 Feb 2012
By using DNA segments isolated from a less deadly form of the malaria-causing parasite Plasmodium, researchers have developed an indirect method for assigning functions to the genes of the lethal human parasite P. More...
falciparum.

Although the complete genome of P. falciparum was sequenced in 2002, its high content of adenine and thymine (A and T) moieties has made it almost impossible to determine the precise function of any of its genes.

To overcome this obstacle investigators at National Jewish Health (Denver, CO, USA) and Yale University (New Haven, CT, USA) constructed a cDNA library from P. knowlesi, which has a lower A + T content compared with P. falciparum. Use of DNA segments from P. knowlesi allowed the investigators to take advantage of the large repertoire of genetic tools available for Saccharomyces cerevisiae, which makes this yeast an ideal system for large-scale functional complementation analyses of parasite genes. After establishing the functions of the P. knowlesi genes they could then match them to corresponding genes in P. falciparum.

The investigators reported in the January 2, 2012, issue of the Journal of Biological Chemistry that they had identified the malaria genes involved in the decarboxylation of phosphatidylserine. The gene, phosphatidylserine decarboxylase, directs the formation of a protein unique to malarial parasites and is a potential therapeutic target.

“The malarial genome has been a black box. Our technique allows us to open that box, so that we can learn what genes in the most lethal human parasite actually do,” said senior author Dr. Dennis Voelker, professor of medicine at National Jewish Health. “This could prove tremendously valuable in the fight against a disease that has become increasingly drug-resistant. This technique could lead to an explosion in knowledge about malaria and the parasite that causes it.”

Related Links:
National Jewish Health
Yale University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Prefilled Tubes
Prefilled 5.0ml Tubes
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers identified 157 metabolites linked to BBB damage, including 25 that appeared in at least two independent studies (Image Credit: Adobe Stock)

Blood Metabolite Patterns May Enable Early Detection of Blood-Brain Barrier Injury

Early injury to the blood-brain barrier (BBB) can precede many neurological disorders but remains difficult to detect noninvasively. Laboratory markers that identify barrier dysfunction before symptoms... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.